Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
186M
-
Number of holders
-
280
-
Total 13F shares, excl. options
-
191M
-
Shares change
-
-2.26M
-
Total reported value, excl. options
-
$6.78B
-
Value change
-
-$112M
-
Put/Call ratio
-
3.61
-
Number of buys
-
141
-
Number of sells
-
-128
-
Price
-
$35.36
Significant Holders of Revolution Medicines, Inc. - Common Stock (RVMD) as of Q1 2025
338 filings reported holding RVMD - Revolution Medicines, Inc. - Common Stock as of Q1 2025.
Revolution Medicines, Inc. - Common Stock (RVMD) has 280 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 191M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (16.6M shares), BlackRock, Inc. (14.7M shares), FARALLON CAPITAL MANAGEMENT LLC (13.5M shares), WELLINGTON MANAGEMENT GROUP LLP (11.8M shares), JANUS HENDERSON GROUP PLC (10.2M shares), BAKER BROS. ADVISORS LP (7.94M shares), Nextech Invest, Ltd. (7.6M shares), FMR LLC (7.54M shares), Paradigm Biocapital Advisors LP (6.18M shares), and STATE STREET CORP (5.8M shares).
This table shows the top 280 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.